Nuclear Factor-κB Enhances ErbB2-Induced Mammary Tumorigenesis and Neoangiogenesis in Vivo
- 1 May 2009
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 174 (5) , 1910-1920
- https://doi.org/10.2353/ajpath.2009.080706
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- IKKα is a critical coregulator of a Smad4-independent TGFβ-Smad2/3 signaling pathway that controls keratinocyte differentiationProceedings of the National Academy of Sciences, 2008
- A cytokine-mediated link between innate immunity, inflammation, and cancerJournal of Clinical Investigation, 2007
- Akt1 governs breast cancer progression in vivoProceedings of the National Academy of Sciences, 2007
- Cell Fate Determination Factor DACH1 Inhibits c-Jun–induced Contact-independent GrowthMolecular Biology of the Cell, 2007
- Somatic Excision Demonstrates that c-Jun Induces Cellular Migration and Invasion through Induction of Stem Cell FactorMolecular and Cellular Biology, 2007
- Nuclear IKK activity leads to dysregulated Notch-dependent gene expression in colorectal cancerProceedings of the National Academy of Sciences, 2007
- DACH1 Is a Cell Fate Determination Factor That Inhibits Cyclin D1 and Breast Tumor GrowthMolecular and Cellular Biology, 2006
- Nuclear factor-κB in cancer development and progressionNature, 2006
- NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasiaNature, 2003
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971